The effect of tolvaptan in heart failure patients with loop diuretic resistance.
Not Applicable
- Conditions
- heart failure
- Registration Number
- JPRN-UMIN000016655
- Lead Sponsor
- Tokyo Women's Medical University, Department of Cardiology
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete: follow-up complete
- Sex
- All
- Target Recruitment
- 50
Inclusion Criteria
Not provided
Exclusion Criteria
1. patients with cardiogenic shock or needs catecholamine or mechanical circulation support 2. intubation 3. obvious bleeding or active gastrointestinal ulceration 4. hemodialysis 5. hyperkalemia (6.0mEq/L) 6. hypernatremia (150mEq/L) 7. hypotension (systolic blood pressure <=85mmHg) or symptomatic hypotension 8. patients who cannot declare thirst or cannot drink water 9. hypersensitivity for Tolvaptan or Mozavaptan 10. expectant mother 11. inappropriate patients judged by the physician in charge
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method